| pubmed-article:17603664 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17603664 | lifeskim:mentions | umls-concept:C0007776 | lld:lifeskim |
| pubmed-article:17603664 | lifeskim:mentions | umls-concept:C2749591 | lld:lifeskim |
| pubmed-article:17603664 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:17603664 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:17603664 | lifeskim:mentions | umls-concept:C0141950 | lld:lifeskim |
| pubmed-article:17603664 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:17603664 | pubmed:dateCreated | 2007-7-2 | lld:pubmed |
| pubmed-article:17603664 | pubmed:abstractText | Semax had a pronounced neuroprotective and antiamnesic effect during focal photoinduced ischemia of the prefrontal cortex. Intranasal administration of Semax for 6 days decreased the volume of cortical infarction and improved retention and performance of conditioned passive avoidance response. | lld:pubmed |
| pubmed-article:17603664 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17603664 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17603664 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17603664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17603664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17603664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17603664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17603664 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17603664 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:17603664 | pubmed:issn | 0007-4888 | lld:pubmed |
| pubmed-article:17603664 | pubmed:author | pubmed-author:ViktorovI VIV | lld:pubmed |
| pubmed-article:17603664 | pubmed:author | pubmed-author:RomanovaG AGA | lld:pubmed |
| pubmed-article:17603664 | pubmed:author | pubmed-author:MyasoedovN... | lld:pubmed |
| pubmed-article:17603664 | pubmed:author | pubmed-author:ShramS ISI | lld:pubmed |
| pubmed-article:17603664 | pubmed:author | pubmed-author:ShakovaF MFM | lld:pubmed |
| pubmed-article:17603664 | pubmed:author | pubmed-author:SilachevD NDN | lld:pubmed |
| pubmed-article:17603664 | pubmed:author | pubmed-author:Kvashennikova... | lld:pubmed |
| pubmed-article:17603664 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17603664 | pubmed:volume | 142 | lld:pubmed |
| pubmed-article:17603664 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17603664 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17603664 | pubmed:pagination | 663-6 | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:meshHeading | pubmed-meshheading:17603664... | lld:pubmed |
| pubmed-article:17603664 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17603664 | pubmed:articleTitle | Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex. | lld:pubmed |
| pubmed-article:17603664 | pubmed:affiliation | Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow, Russia. romanovaga@mail.ru | lld:pubmed |
| pubmed-article:17603664 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17603664 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
